Pharmaceutical Giant, Serono, Agrees to Pay $44.3 Million to Settle False Claims Act Case
Pharmaceutical Giant, Serono, Agrees to Pay $44.3 Million to Settle False Claims Act Case
Pharmaceutical manufacturers Serono Laboratories Inc., EMD Serono Inc., Merck Serono S.A, and Ares Trading S.A. have agreed to pay $44.3 million to resolve False Claims Act allegations in connection with the marketing of the drug Rebif.